Announcements

We are pleased to announce that the 2024 Tu Youyou Award has been conferred upon Richard DiMarchi and Rolf Müller, in recognition of their significant contributions to natural products chemistry and medicinal chemistry.

Richard DiMarchi Indiana University, USA	Prof. Richard DiMarchi is a Distinguished Professor of Chemistry and Gill Chair in Biomolecular Sciences at Indiana University, USA. He is a member of the National Academy of Medicine and the National Inventors Hall of Fame. Dr. DiMarchi is a former Group Vice President at Eli Lilly and later at Novo Nordisk. He is recognized for his contributions to the discovery and development of rDNA-derived Humulin®, Humalog®, rGlucagon®, and Forteo®. His academic research has broadened the understanding of glucagon and incretin physiology and pioneered the discovery of single-molecule multi-mechanism agonists for the treatment of diabetes and obesity. The central element to success has been the chemical vision and technology to install within single molecules simultaneous agonism at related G-protein coupled receptors, coupled to the counter-intuitive discovery that glucagon and GIP agonism could synergize the therapeutic efficacy of GLP-1. These peptides and their conceptual approach have transformed the management of excessive body weight to a condition comparable to how hypertension, adult-onset diabetes, and excess cholesterol are medicinally managed.
“Professor DiMarchi was recognized by the 2024 Tu Youyou Award Committee members as being an exceptional leader in the medicinal chemistry of peptides and proteins of natural origin, and as a pioneer in the field of chemical biotechnology. His very important discoveries have led to breakthroughs in new drugs related to the therapy of diabetes and obesity. He has been named as an inventor on a very large number of patents, and he has had initially a highly successful scientific and administrative career in industry, which was followed by over two decades in academia as a distinguished professor.” —Prof. Dr. A. Douglas Kinghorn, Chair of the Award Committee
Rolf Müller Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany; Helmholtz Centre for Infections Research (HZI), Germany; Saarland University, Germany	Prof. Rolf Müller is the Founding and Managing Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Professor of Pharmaceutical Biotechnology at Saarland University, Germany. Having received his training from the University of Bonn, he held research positions at the University of Washington, USA, and Braunschweig University of Technology, Germany, prior to his appointment as professor to Saarland University. His laboratory has dedicated itself to the exploration of bacterial natural-product biosynthetic pathways for more than 20 years and has extensive experience in working with myxobacteria and other microbial producer strains. Starting from the isolation and characterization of new microorganisms, the scope of work includes microbiology-, biotechnology-, bioinformatics-, and chemistry-based approaches to exploit these isolates as sources of new drugs with a special focus on novel anti-infectives. Müller and his team apply a variety of state-of-the-art analytical methods and biological assays to perform biological and chemical characterizations of the identified compounds. Prof. Müller has received several awards, including the prestigious Gottfried Wilhelm Leibniz Prize, the PHOENIX Pharmacy Research Award, the DECHEMA Prize, and the Inhoffen Medal, as well as being an elected member of acatech, Leopoldina, and the German Academy of Sciences and Literature.
“The 2024 Tu Youyou Award Committee members were highly impressed by the truly outstanding past and ongoing contributions of Professor Müller in both microbial natural products isolation chemistry and in biosynthesis, as well as in the development of lead compounds for their potential in treating human diseases, through his global connections with various major funding agencies. He is also a dedicated teacher who has trained numerous graduate students and postdoctoral fellows, and he has lectured on his research in countries all over the world.” —Prof. Dr. A. Douglas Kinghorn, Chair of the Award Committee

The achievements of Richard DiMarchi and Rolf Müller highlight the transformative impact of natural products chemistry and medicinal chemistry. We congratulate them and invite the global academic community and public to join us in celebrating their significant contributions.

2024 Award Committee
Committee Chair:

• Prof. Dr. A. Douglas Kinghorn, Ohio State University, USA.
  

Committee Members (listed in alphabetical order):

• Prof. Angelo Fontana, University of Naples “Federico II”, Italy;
• Prof. Binghe Wang, Georgia State University, USA;
• Dr. Diana Pinto, University of Aveiro, Portugal;
• Prof. Hideaki Kakeya, Kyoto University, Japan;
• Dr. RuAngelie Edrada-Ebel, University of Strathclyde, UK;
• Prof. Thomas Prisinzano, University of Kentucky, USA
• Prof. Wei Li, University of Tennessee Health Science Center, USA.

About the Tu Youyou Award:
The 2024 Tu Youyou Award includes a total monetary prize of 100,000 Swiss Francs and a medal for each recipient. Established in 2016 to honor the pioneering spirit of Nobel laureate Tu Youyou, the Tu Youyou Award is an international award honoring exceptional scholars dedicated to the fields of natural products chemistry and medicinal chemistry.

For further information about the award and the winners, please visit the Tu Youyou Award website.

Conference: The 56th Symposium of the Polish Society of Histochemists and Cytochemists
Organizer: Polish Society of Histochemists and Cytochemists
Date: 28–31 May 2025
Place: Hotel Anders, ul. Spacerowa 2, 14-133 Stare Jabłonki, Poland

MDPI journals will be exhibitors at PHTC 2025, which will be held in Olsztyn, Poland, from 28 to 31 May 2025.

The 56th Symposium, titled “From the Silver to Dream—Histochemistry is Good for Everything,” is organized by the Olsztyn Branch of the Polish Society of Histhoms and Cytochemists.

The following MDPI journals will be represented:

• Cells;
• Biomolecules;
• JDB.

If you will be attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://pthc2025.pl/.

MDPI is excited to collaborate with Toronto Metropolitan University to host an engaging Scientific Publishing Workshop aimed at empowering scholars with the knowledge and tools needed to succeed in academic publishing. This workshop will delve into the key aspects of MDPI’s open access publishing framework, offering an in-depth exploration of journal selection, the editorial workflow, and the essentials of publication ethics. Participants will also gain practical advice on improving their scientific writing and effectively addressing reviewer comments, with guidance from an experienced professional. This session promises to equip attendees with valuable skills to elevate their publishing journey.

Workshop Highlights:

• Learn How to Better Write and Structure a Research Article;
• How to Choose Where to Publish Academic Work;
• How to Respond to Reviewer Comments;
• Reasons for Rejection During Pre-Check;
• How to Navigate Through Ethics and AI Use.

Date: 15 May 2025
Time: 12:00–1:30 p.m.
Venue: Toronto Metropolitan University

Program:

We are thrilled to share the updated Exceptional Reviewers List 2025. This program was designed to recognize and honor scholars who have delivered consistently exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, Cells (ISSN: 2073-4409) recognizes the significant role our reviewers play in maintaining the quality and integrity of the articles we publish. Thank you to our pool of excellent reviewers.

We would like to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist in Cells’ peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback, and contributing to academic rigor are truly commendable.

The Exceptional Reviewers List was introduced in May 2025. Each quarter, we will be selecting a group of outstanding reviewers and introducing them here.

Q1
Name: Dr. Wei Wen Lim
Affiliation: National Heart Research Institute Singapore, National Heart Centre Singapore, 169609, Singapore

Name: Prof. Dr. Jae-Wook Oh
Affiliation: Department of Stem Cell and Regenerative Biotechnology, KIT, Konkuk University, Seoul, Republic of Korea

Name: Dr. Giovanna Liguori
Affiliation: Institute of Genetics and Biophysics Adriano Buzzati Traverso, Naples, Italy

Name: Dr. Yoichi Ezura
Affiliation: Department of Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan

Name: Dr. Bruno Brando
Affiliation: Hematology Laboratory and Transfusion Center, Legnano General Hospital, 20025 Legnano (Milano), Italy

Name: Dr. Benoit Miotto
Affiliation: Team Epigenetics and Nuclear Functions in Human Diseases, Université Paris Cité, Institut Cochin, INSERM U1016, CNRS UMR8104, F-75014 Paris, France

Name: Dr. Yongqing Liu
Affiliation: Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, KY, USA

Name: Dr. Tomaž Büdefeld
Affiliation: Centre for Human Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, 2000 Maribor, Slovenia
“In the era of AI-powered generators, the revision undertaken by independent reviewers based on their prior work experience and accumulated knowledge is paramount to ensure the sustained flourishing of the research community.”

Name: Dr. Cláudia Saraiva
Affiliation: INSERM-Université Bourgogne U1231, Equipe GAD Génétique des Anomalies du Développement, Dijon, France

Name: Prof. Dr. Gundula Schulze-Tanzil
Affiliation: Institute of Anatomy and Cell Biology, Paracelsus Medical University, Nuremberg and Salzburg, 90419 Nuremberg, Germany
“Reviewing for Cells is guided by a comfortable platform: Cells addresses emerging fields. Hence, I benefit by updating my scientific point of view and I feel that my comments are generally addressed.”

Name: Dr. Abhishek Tyagi
Affiliation: Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA

Name: Dr. Riya Thomas
Affiliation: Seattle Children's Research Institute, 1900 9th Ave, Seattle, WA 98101, USA

Name: Prof. Dr. Mirko Manetti
Affiliation: Department of Experimental and Clinical Medicine, Section of Anatomy and Histology, University of Florence, Florence, Italy

Name: Prof. Dr. Giuseppe Biagini
Affiliation: Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41100 Modena, Italy

Name: Dr. Wenjing Zhang
Affiliation: Department of Pathology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA

Name: Dr. Mary Gilbert
Affiliation: Office of Research and Development, Center for Public Health and Environmental Assessment, US Environmental Protection Agency, Research Triangle Park, NC 27709, USA

Name: Dr. Sudeep Kumar
Affiliation: Cincinnati Children's Hospital Medical Center 3333 Burnet Ave Cincinnati, OH 45229, USA

Name: Dr. Christine Hellweg
Affiliation: Department of Radiation Biology, Institute of Aerospace Medicine, German Aerospace Center (DLR), 51147 Cologne, Germany

Name: Dr. Ignacio Torrecilla
Affiliation: Department of Oncology, University of Oxford: Oxford, Oxfordshire, UK

Name: Prof. Dr. Margaret L. Britz
Affiliation: Tasmanian Institute of Agriculture, University of Tasmania, Hobart, TAS 7005, Australia
“As a retired senior academic, I have the time and experience to add value to the peer-review processes. It is a duty that requires considerable effort, to spot the gems as well as the glitches, by thorough analysis of data and checking all claims based on data and the literature cited. It is also a two-way conversation aimed at improving the submitted manuscripts so that any resulting publication enriches our knowledge through accurate reporting. I gain a lot out of this and hope my well-meant feedback adds value.”

Name: Dr. Sarath Babu Nukala
Affiliation: Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA

Name: Dr. Jezabel Rodriguez-Blanco
Affiliation: Darby Children’s Research Institute, Hollings Cancer Center, Medical University of South Carolina, Miami, USA

Name: Dr. Phillip Domeier
Affiliation: Department of Microbiology and Immunology, University of British Columbia: Vancouver, British Columbia, Canada

Name: Dr. Jose Rodriguez-Alvarez
Affiliation: Department Bioquímica i Biologia Molecular, Institut de Neurociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain

Name: Dr. Michał Zarobkiewicz
Affiliation: Department of Clinical Immunology, Medical University of Lublin, Lublin, Poland

Name: Dr. Béla Papp
Affiliation: Institut National de la Santé et de la Recherche Médicale, Inserm UMR 1342, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Paris, France

Name: Dr. Kristina Pilipović
Affiliation: Faculty of Medicine, University of Rijeka, Rijeka, Croatia

Name: Prof. Dr. Johannes Boltze
Affiliation: School of Life Sciences, University of Warwick, Coventry CV4 7AL, UK
“The review process is well organized and straightforward. The professional editorial team provides tremendous support, making it a good experience for reviewers and authors alike.”

Name: Dr. Harinarayanan Janakiraman
Affiliation: Michael DeBakey Department of Surgery, Baylor College of Medicine, Houston TX 77030, USA

Name: Dr. Qing Jun Wang
Affiliation: College of Medicine, University of Kentucky, Lexington, KY 40536, USA

You can read more testimonials at the following link: https://www.mdpi.com/testimonials?type=all&journal_id=32&page_count=20.

Conference: Chinese Society of Plant Physiology and Plant Molecular Biology 2025 Annual Meeting
Organization: Chinese Society of Plant Biology
Date: 28 July–01 August 2025
Place: Heilongjiang, China

MDPI journals will be present as exhibitors at the Chinese Society of Plant Physiology and Plant Molecular Biology 2025 Annual Meeting, which will be held at the Sheraton Harbin Xiangfang Hotel, Heilongjiang, China, from 28 July to 1 August 2025.

This conference will cover the following topics:

1. Plant metabolism and nutritional health;
2. Plant development and cell fate;
3. Plant carbon sink and physiological ecology;
4. Phytoremediation biology and sustainable agriculture;
5. Plant adversity perception and trait plasticity;
6. Plant–microbe symbiosis and nutrition;
7. Crop molecular design breeding;
8. Plant–biotic interactions and crop disease and pest resistance;
9. Plant epigenetics;
10. Interdisciplinary forum;
11. Young scholars forum;
12. Youth forum on natural product biosynthesis;
13. Young scholars’ growth and journal development forum.

The following MDPI journals will be represented:

• Plants;
• Current Issues in Molecular Biology (CIMB);
• Agriculture;
• International Journal of Molecular Sciences (IJMS);
• Horticulturae;
• Agronomy;
• International Journal of Plant Biology (IJPB);
• Epigenomes;
• Cells;
• BioTech;
• Phycology;
• Metabolites;
• Microorganisms;
• Methods and Protocols.

If you will be attending this conference, please feel free to visit our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.

The First International Organoid Conference (ISFO 2025) is the first congress held by the Internation Society for Organoid (ISFO), which is dedicated to unique advantages in various interdisciplinary fields around organoids, such as disease modeling, clinical immunology, pharmacotoxicology, regenerative medicine and is poised to be one of the most promising research tools for clinic studies and drug development.

The following MDPI journals will be represented at the conference:

• Cells;
• Organoids;
• JDB;
• Bioengineering;
• Biomedicines.

If you are planning to attend the conference mentioned above, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth #29 and answering any questions you may have.

For more information about the conference, please visit the following website: https://www.isorganoid.org/programs/details/26/6.html.

We are honored to introduce the award committee for the 2024 Tu Youyou Award, composed of distinguished scientists from around the world whose research covers diverse areas of natural product chemistry, pharmacognosy, and drug discovery. Their broad expertise and pioneering contributions have significantly advanced medicinal and natural products research.

Through their collective insights, rigorous evaluation, the committee has carefully selected this year’s award recipients, recognizing exceptional achievements in the field.

We sincerely thank these distinguished scholars for their efforts and dedication to upholding the standards of the Tu Youyou Award.  Below is the list of committee members. For more information about the Tu Youyou Award, please visit https://tuyouyouprize.org/. 

Chair:

Prof. Dr. A. Douglas Kinghorn Ohio State University, USA

Prof. Dr. A. Douglas Kinghorn is a leading expert in pharmacognosy and natural products research. He is recognized for his key contributions to discovering bioactive compounds from plants, especially in anticancer, cancer chemopreventive, and substances with a sweet taste and taste-modifying agents. His prolific contributions include over 590 peer-reviewed works and book chapters and edited or co-edited 40 scientific volumes.

Prof. Angelo Fontana University of Naples “Federico II”, Italy	Angelo Fontana is a Professor of Organic Chemistry at the University of Naples “Federico II” in Italy and serves as Director of the Institute of Biomolecular Chemistry at the National Research Council (CNR). His research focuses on bioactive small molecules derived from marine eukaryotes, with a particular interest on their pharmaceutical applications in immunology and oncology. He also explores their potential as molecular tools for probing and modulating complex biological systems. Prof. Fontana is a co-founder of BioSEArch SRL and has been recognized with numerous grants and honors, including the Apivita Award from the Phytochemical Society of Europe.
Prof. Binghe Wang Georgia State University, USA	Prof. Binghe Wang’s lab works on drug design, drug delivery, click chemistry, chemical biology, new diagnostics, and gaseous signaling molecules such as carbon monoxide and hydrogen sulfide. His interdisciplinary research supports advances in cancer, infectious diseases, organ protection, inflammation, and other areas.
Dr. Diana Pinto University of Aveiro, Portugal	Dr. Diana Pinto, an Associate Professor at the University of Aveiro, specializes in organic synthesis of bioactive heterocyclic compounds, sustainable catalysis (organo-, heterogeneous, and biocatalysis), and natural product research, including isolation, characterization, and total synthesis.
Prof. Hideaki Kakeya Kyoto University, Japan	Prof. Hideaki Kakeya conducts cutting-edge research in chemical biology, high-throughput screening, and biosynthesis of bioactive natural products for system chemotherapy and other therapeutic applications.
Dr. RuAngelie Edrada-Ebel University of Strathclyde, UK	Prof. RuAngelie Edrada-Ebel heads the Natural Products Metabolomics Group (NPMG), specializing in marine natural products discovery and metabolomics-driven drug development. A recognized expert in bioactive metabolites, she collaborates with industry and academia to address antimicrobial resistance and sustainable bioprospecting. She serves on the Editorial Board of Marine Drugs and holds two patents in the field.
Prof. Thomas Prisinzano University of Kentucky, USA	Prof. Thomas Prisinzano combines medicinal and natural product chemistry to explore neurotransmitter systems and develop treatments for drug abuse and pain. He has received several prestigious awards, including the Innovator Award from the College on Problems of Drug Dependence.
Prof. Wei Li University of Tennessee Health Science Center, USA	A distinguished professor and Director of the Drug Discovery Center, Prof. Wei Li is also the founder of SEAK Therapeutics, and the 2025 Chair-Elect of the Drug Discovery and Development Division of the American Society of Pharmacology and Experimental Therapeutics (ASPET). His work focuses on medicinal chemistry and small molecule drug discovery, with over 200 publications and 15 issued US patents.

The 2025 Annual Congress of the European Association for Cancer Research (EACR 2025) is a four-day congress dedicated to basic, preclinical, and translational cancer research across a wide breadth of topics. The conference will highlight the latest research and bring together members of the cancer research community to stimulate innovation and build knowledge, connections, and collaborations.

The following MDPI journals will be represented at the conference:

• Cancers;
• IJMS;
• Marine Drugs;
• Biomedicines;
• Healthcare;
• CIMB;
• Cells;
• Current Oncology;
• JPM;
• Neurology International;
• DNA.

If you are planning to attend the above conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth #86 and answering any questions that you may have.

For more information about the conference, please visit the following website: https://2025.eacr.org.

World Malaria Day, observed annually on 25 April, is a global reminder of the urgent need to stay focused on the fight against malaria—a preventable and treatable disease that still threatens millions of lives, especially in vulnerable communities. Despite considerable progress over the past two decades, malaria continues to take a heavy toll, particularly in sub-Saharan Africa, where children under five remain at most risk.

The theme for 2025, “Malaria Ends with Us: Reinvest, Reimagine, Reignite”, is a powerful call to action. It is a strong reminder that the fight against malaria is not over, and that the power to end it lies with all of us.

In recognition of this vital cause, MDPI is spotlighting impactful research across a selection of its journals, highlighting contributions that advance the understanding, prevention, and treatment of malaria. Featured journals include Cells, Insects, Journal of Clinical Medicine (JCM), Metabolites, Parasitologia, Pathogens, Pharmaceuticals, Reports, and TropicalMed. By bringing these articles to the forefront, MDPI reaffirms its commitment to open access knowledge and global health equity.

Prof. Tu Youyou was awarded the Nobel Prize in Physiology or Medicine in 2015 for discovering artemisinin, a drug that has significantly reduced the mortality rates for patients suffering from malaria.

To honor Prof. Tu Youyou’s remarkable contributions and to continue with her achievements, MDPI established the Tu Youyou Award in 2016. This award aims to acknowledge exceptional scholars committed to the research fields of natural products chemistry and medicinal chemistry.

The winners of the 2024 Tu Youyou Award will be announced on 30 April. Visit the award website for the latest updates!

“Blood Source and Anesthetics Effects on the Maintenance of Anopheles darlingi in the Lab-Rearing Condition”
by José Daniel Costa Pontual, Natália Vitória Coelho, Najara Akira Costa dos Santos, Alessandra da Silva Bastos, Jéssica Evangelista Araújo, Alice Oliveira Andrade, Jansen Fernandes Medeiros and Maisa da Silva Araujo
Insects 2025, 16(3), 281; https://doi.org/10.3390/insects16030281

“Identification of Bioactive Metabolites of Capirona macrophylla by Metabolomic Analysis, Molecular Docking, and In Vitro Antiparasitic Assays”
by Joseph Evaristo, Elise de Laia, Bruna Tavares, Esdras Mendonça, Larissa Grisostenes, Caroline Rodrigues, Welington do Nascimento, Carolina Garcia, Sheila Guterres, Fábio Nogueira et al.
Metabolites 2025, 15(3), 157; https://doi.org/10.3390/metabo15030157

“Duplication of a Type-P5B-ATPase in Laverania and Avian Malaria Parasites and Implications About the Evolution of Plasmodium”
by Mark F. Wiser
Parasitologia 2025, 5(1), 6; https://doi.org/10.3390/parasitologia5010006

“Effect of Health Education Intervention on Knowledge and Adherence to Intermittent Preventive Treatment of Malaria in Pregnancy Among Women”
by Pauline N. Atser, Gommaa Hayat and Uchenna B. Okafor
Healthcare 2025, 13(2), 105; https://doi.org/10.3390/healthcare13020105

“Uncovering the Mechanism of Action of Antiprotozoal Agents: A Survey on Photoaffinity Labeling Strategy”
by Alessandro Giraudo, Cristiano Bolchi, Marco Pallavicini, Roberto Di Santo, Roberta Costi and Francesco Saccoliti
Pharmaceuticals 2025, 18(1), 28; https://doi.org/10.3390/ph18010028

“Contribution of Magnetic Resonance Imaging Studies to the Understanding of Cerebral Malaria Pathogenesis”
by Alicia Comino Garcia-Munoz, Isabelle Varlet, Georges Emile Grau, Teodora-Adriana Perles-Barbacaru and Angèle Viola
Pathogens 2024, 13(12), 1042; https://doi.org/10.3390/pathogens13121042

“Prophylaxis Failure and Successful Management of Delayed-Onset Malaria with Renal Complications: A Case Report with Oral Artemether-Lumefantrine Treatment”
by Ilir Tolaj, Gramoz Bunjaku, Murat Mehmeti and Yllka Begolli
Reports 2023, 6(4), 53; https://doi.org/10.3390/reports6040053

“Sensitivity Assessment of a Multiplex and Real-Time PCR Protocols for the Detection of Malaria in External Quality Control Samples in the Malaria Reference Center in Greece”
by Nikolaos Tegos, Christos Goumenopoulos, Anastasia Mpimpa, Vasilios Papavasilopoulos, Stavroula Beleri and Eleni Patsoula
Parasitologia 2024, 4(2), 150-161; https://doi.org/10.3390/parasitologia4020013

“Prevention of Malaria in Pregnant Women and Its Effects on Maternal and Child Health, the Case of Centre Hospitalier de Kingasani II in the Democratic Republic of the Congo”
by Japhet Kabalu Tshiongo, Trésor Zola Matuvanga, Patrick Mitashi, Vivi Maketa, Henk D. F. H. Schallig, Petra F. Mens, Hypolite Muhindo Mavoko and Junior Matangila Rika
Trop. Med. Infect. Dis. 2024, 9(5), 92; https://doi.org/10.3390/tropicalmed9050092

“An Epidemiological Survey of Malaria Infection in Espírito Santo State, Brazil, from 2007 to 2017”
by Nayna Carvalho Oliveira, Lais Rosa Boscalha, Cinthia Emerich Toledo, Felipe Sarlo Pezzin, Bruno Costanza Cisari, Suellen Rodrigues Maran, Laís Rodrigues Diniz, Pedro Henrique Schultz Corcino Freitas, Adenilton Cruzeiro, Frederico Eutropio et al.
Parasitologia 2023, 3(3), 215-222; https://doi.org/10.3390/parasitologia3030022

“Low Prevalence of Plasmodium falciparum Histidine-Rich Protein 2 and 3 Gene Deletions—A Multiregional Study in Central and West Africa”
by Tina Krueger, Moses Ikegbunam, Abel Lissom, Thaisa Lucas Sandri, Jacques Dollon Mbama Ntabi, Jean Claude Djontu, Marcel Tapsou Baina, Roméo Aimé Laclong Lontchi, Moustapha Maloum, Givina Zang Ella et al.
Pathogens 2023, 12(3), 455; https://doi.org/10.3390/pathogens12030455

“Impact of the COVID-19 Pandemic on Malaria Control in Africa: A Preliminary Analysis”
by Liping Gao, Qi Shi, Zhiguo Liu, Zhenjun Li and Xiaoping Dong
Trop. Med. Infect. Dis. 2023, 8(1), 67; https://doi.org/10.3390/tropicalmed8010067